Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: AB Foods Reports Sales Rises Across Portfolio

Thu, 16th Jan 2020 08:03

(Alliance News) - Associated British Foods highlighted a string of trading updates from UK consumer companies on Thursday.

AB Foods said its outlook is unchanged following a good first quarter for fast fashion store chain Primark.

Group sales for the 16 weeks to January 4 were up 4% year-on-year at constant currency, and 3% ahead at actual rates.

Sales at high-street chain Primark were up 4.5% year-on-year at constant currency and 3.0% ahead at actual exchange rates. This was, however, "almost entirely" driven by an increase in selling space. The like-for-like performance improved, AB Foods said without specifying numbers, driven by a marked upturn in the eurozone.

In the UK, Primark sales were up 4.0% driven by new selling space and a "marginal" decline in like-for-like sales. Sales in the eurozone were up 5.1% with the improvement in like-for-like sales seen in the final quarter of the previous financial year continuing. The US also delivered like-for-like sales growth.

"As expected, operating profit margin in the period decreased, with the effect of purchases contracted at a stronger US dollar exchange rate than last year but partially mitigated by cost reductions in both the cost of goods and overheads," said AB Foods.

In the current financial year, AB Foods expects to open 18 new Primark stores, with its first store in eastern Europe, in Ljubljana, Slovenia exceeding expectations.

Elsewhere in the AB Foods portfolio, Sugar revenue was up 7% at constant currency and Grocery sales flat, while Agriculture revenue was 10% ahead of a year ago and Ingredients sales up 3%.

The stock was up 2.1% in early dealings Thursday.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: up 3.52 points at 7,646.32

----------

Hang Seng: up 0.2% at 28,824.69

Nikkei 225: closed up 0.1% at 23,933.13

DJIA: closed up 90.55 points, 0.3%, at 29,030.22

S&P 500: closed up 0.2% at 3,289.29

----------

GBP: firm at USD1.3039 (USD1.3024)

EUR: soft at USD1.1147 (USD1.1159)

Gold: up at USD1,552.91 per ounce (USD1,549.30)

Oil (Brent): up at USD64.34 a barrel (USD63.70)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Thursday's Key Economic Events still to come

0930 GMT UK Bank of England credit conditions survey

1000 CET France IEA oil market report

0830 EST US import and export price indices

0830 EST US advance monthly sales for retail & food services

0830 EST US initial jobless claims

1000 EST US manufacturing & trade: inventories & sales

1000 EST US NAHB housing market index

1030 EST US EIA weekly natural gas storage report

----------

The UK property market has been given a lift by the general election result, according to surveyors. The number of house sales taking place across the UK has increased for the first time in seven months, the Royal Institution of Chartered Surveyors report for December said. Agreed sales in London and East Anglia in particular saw an improvement, although sales reportedly weakened in Northern Ireland and Scotland. Inquiries from buyers are also now generally on the up, after previously falling back in November, the report found.

----------

Consumer prices in Germany rose by 1.4% on an average annual basis in 2019, the Federal Statistical Office of Germany said. The average year-on-year increase in 2019 was down on the 1.8% average rise seen in 2018. The deceleration was attributed to a marked slowdown in energy price inflation to 1.4% in 2019 from 4.6% in 2018. Turning to December, the annual German consumer price inflation rate was 1.5%, accelerating from 1.1% in November. December's reading marked the first acceleration since July.

----------

BROKER RATING CHANGES

----------

BARCLAYS CUTS GLAXOSMITHKLINE TO 'UNDERWEIGHT' (EQUAL WEIGHT) - PRICE TARGET 1650 PENCE

----------

JEFFERIES CUTS DIAGEO TO 'HOLD' (BUY) - PRICE TARGET 3600 PENCE

----------

BARCLAYS CUTS SPIRENT TO 'UNDERWEIGHT' ('EQUAL WEIGHT') - TARGET 190 (159) PENCE

----------

COMPANIES - FTSE 100

----------

Pearson said it met guidance in 2019 though predicts challenging trends in US Higher Education Courseware to continue. The educational publisher said underlying revenue was flat in 2019 and adjusted operating profit GBP590 million. US Higher Education Courseware revenue declined by 12%, though there was "modest" growth in digital revenue. Pearson said it expects the trends seen in the unit to continue, with heavy declines in print partially offset by modest growth in digital. For 2020, Pearson expects to deliver adjusted operating profit between GBP500 million to GBP580 million, including the 25% stake in Penguin Random House that it recently agreed to sell for USD675 million. Pearson said Chief Financial Officer Coram Williams will be leaving the company and will be replaced by Sally Johnson, deputy financial officer. Williams will step down from his position and from the board later this year.

----------

Whitbread said it delivered a "robust" third quarter despite challenging conditions in the UK. Total UK sales in the third quarter were up 0.3%, though fell 1.3% on a like-for-like basis. UK & International total sales growth was 1.0%. The start of the fourth quarter has seen more positive regional UK data due to lower comparators and the timing of Christmas, the company said, along with the continuation of the strong London market. However, "it is still early" in the fourth quarter and "a level of caution" remains on the UK hotel environment, Whitbread added. Looking into the 2021 financial year, Whitbread noted that the UK backdrop remains "uncertain" and sustained industry inflation continues. Whitbread said it will take a cautious approach to hotel demand and expects a net margin headwind of around GBP60 million, comprising wage inflation and ongoing investment, partially offset by its efficient programme.

----------

COMPANIES - FTSE 250

----------

Recruitment firm Hays expects a fall in first half revenue due to strikes in France, the bushfires in Australia, the UK general election, and a slowdown in activity in Germany. Hays said it expects operating profit for the first half of around GBP100 million, which would be down from GBP124.1 million a year ago. Group net fees for the second quarter, which ended December 31, fell by 7% on a headline basis and 4% like-for-like. Like-for-like net fees in its Temp and Perm businesses declined by 3% and 6% respectively. In Australia & New Zealand, net fees were down 7% like-for-like and Germany down 9%, while the UK & Ireland fell 4%.

----------

COMPANIES - OTHER MAIN MARKET AND AIM

----------

Seawave Investment - the firm which, according to Lekoil, brokered a loan to the Nigerian oil firm from fake Qatari investors - will address the matter, the Financial Times reported. Lekoil late Monday said it parted, "in good faith" with USD600,000 to Seawave which acted as an introducer to those "purporting to be the Qatar Investment Authority". At the start of January, Lekoil announced it agreed a USD184.0 million loan from QIA for drilling and development at the Ogo field off the coast of Nigeria. Seawave's Managing Partner Bismarck Abrafi told the newspaper that the company will respond to the allegations. "We will issue a full statement and everything will be clear," Abrafi told the FT.

----------

COMPANIES - INTERNATIONAL

----------

The Japanese lawyer nicknamed the "Razor" who was spearheading Carlos Ghosn's defence said Thursday he is quitting the case after his client skipped bail and fled Japan for Lebanon. Junichiro Hironaka's office issued a brief statement saying they had "filed with the Tokyo District Court letters of resignation for all lawyers...connected with all cases related to Carlos Ghosn". Hironaka, 74, who earned his nickname for sharp legal strategies and an enviable acquittal record, has said he was "dumbfounded" by Ghosn's escape, which he discovered via the media on the morning his client fled. Another one of Ghosn's legal team, Takashi Takano, has also thrown in the towel on the case, a source close to his office told AFP.

----------

Thursday's Shareholder Meetings

Cardiff Property

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.